• NGLY1 in The New Yorker!

    Open science and social media were key in the discovery and growth of the NGLY1 rare disease community. Article by Seth Mnookin.

  • NGLY1 Deficiency Research

    In June 2012, the Freeze Lab pioneered research into the clinical treatment of the rare disorder, N-glycanase deficiency.

  • NGLY1 Families Connect

    On February 28, 2014, researchers and 5 NGLY1 families from across the world met for the first ever symposium on N-glycanase deficiency.

Thursday, September 27, 2012

New NGLY1 Support Group & Website

This is a new website for families dealing with N-glycanase deficiency.

N-glycanase deficiency is caused by errors in the NGLY1 gene.  NGLY1 encodes the production of the enzyme N-glycanase, which is essential for the degradation of misfolded, N-linked glycoproteins within cells throughout the body.

N-glycanase is a highly conserved protein, meaning that it is essential across species.  Even yeast need a form of N-glycanase to function properly.

Researchers are just now learning what this enzyme does in humans.

In June 2012, our son Bertrand was the first case of an NGLY1 disorder published in medical literature.

We're hoping to find treatments for N-glycanase deficiency within our son's lifetime. To that end, we have funded research at Sanford-Burnham Medical Research Institute (SBMRI) into better understanding the condition and testing potential off-label treatments.

Recently, other cases of N-glycanase deficiency have come to light.

We hope to connect NGLY1 families together for support, research, discovery, and some day a cure.